WASHINGTON, April 2 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Topamax tablets (topiramate) to prevent seizures.
WASHINGTON, May 12 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of a drug designed for the treatment of restless legs syndrome.
WASHINGTON, Sept. 5 (UPI) -- The U.S. Food and Drug Administration announced approval Wednesday of the first generic versions of the blood pressure and heart medication Coreg.
WASHINGTON, July 2 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Lamisil (terbinafine hydrochloride) tablets to treat nail fungus infection.
WASHINGTON, April 24 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Ambien (zolpidem tartrate) for the treatment of insomnia.
ABBOTT PARK, Ill., Feb. 27 (UPI) -- U.S. pharmaceuticals company Abbott Laboratories Inc. is cutting 200 research jobs and "several hundred" sales jobs following an acquisition, the company said.
BRISTOL, Tenn., Dec. 27 (UPI) -- U.S. firm Watson Pharmaceuticals has acquired the U.S. rights to Stellar Pharmaceuticals' Uracyst to treat interstitial cystitis.
CORONA, Calif., March 13 (UPI) -- California's Watson Pharmaceuticals Inc. said Monday it was paying about $1.9 billion for generic drug maker Andrx Corp.
REYKJAVIK, Iceland, Oct. 18 (UPI) -- Iceland's Actavis Group will pay $810 million to buy Alpharma Inc.'s generic drug business.
BOMBAY, March 29 (UPI) -- Lupin Pharmaceuticals Inc. of India has made a deal with Allergan Inc. of California to market a pediatric eye solution to treat bacterial conjunctivitis.
